PTAB reveals reasons for cancelling Novartis patent

Managing IP is part of Legal Benchmarking Limited, 4 Bouverie Street, London, EC4Y 8AX

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

PTAB reveals reasons for cancelling Novartis patent

Rani Mehta
January 25 2023
NovartisCOVER.jpg
Credit: Taljat / Adobe Stock

The Patent Trial and Appeal Board found that claims in a Novartis patent were obvious over the prior art

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

NewsUnited StatesPatentsLife sciences
rani-mehta-300px.png
Rani Mehta
Senior Reporter Managing IP
Contact
Rani reports on all aspects of IP in the US and the Americas, particularly trademarks and copyright. Based in New York, she covers in-house and private practice lawyers' concerns and insights into the market.
more from across site and SHARED ros bottom lb

More from across our site

Patents
Europe viewed from space at night with city lights in European Union member states, global EU business and finance, satellite communication technology, 3D render of planet Earth, world map from NASA
State of the market: The steady performers of Europe’s IP industry
A comparison of the 2024 and 2025 editions of the Managing IP EMEA Awards reveals the firms and companies that have been dominating Europe’s IP market year after year
Sukanya Sarkar, May 21 2025
Trademarks
TuesdayINTA.jpg
Tuesday at INTA: BD tips for lawyers | Tackling SEPs
Tuesday's coverage includes BD tips for aspiring partners, and a foray into the world of SEPs
Rani Mehta, May 21 2025
What Corporates Want
Copy of What Corporates Want 2025 (1).png
US IP counsel left wanting on value for money
Exclusive data reveals law firms are failing to go above and beyond for their corporate clients, with in-house counsel saying advisers should consider more transparent billing processes
Max Walters, May 20 2025
Patents
Photo merge template.png
Behind the case: How Osborne Clarke and EIP broke new ground at the CoA
Arty Rajendra and Gary Moss discuss why ‘thorough and intense’ preparation, plus the odd glass of wine, led to a record FRAND victory for their client
Max Walters, May 20 2025
Trademarks
INTA.jpg
Monday at INTA: ‘Game-changing’ TM developments in China | Agentic AI
Monday’s coverage includes news of a potentially 'game-changing' trademark development in China and how practitioners are using AI
Rani Mehta, May 19 2025
Trademarks
TMrankings.png
IP STARS trademark rankings to be revealed
Managing IP gives a taster of the numbers behind this year’s IP STARS trademark rankings, and looks back at our 2025 award winners
May 19 2025
Trademarks
INTACeremonies.jpg
Sunday at INTA: Law firms must develop 'industry expertise' | IP office updates
Updates from IP offices, the shifting requirements of in-house counsel, and news of London 2026 were among major talking points on Sunday
Max Walters, May 19 2025
Trademarks
MIP Podcast newsletter header banner sample-2000.jpg
The IP Lounge: INTA CEO on IP ‘positivity’ and London 2026
Etienne Sanz de Acedo discusses the association’s three-year plan, what he is looking forward to in San Diego, and why London came calling for 2026
Max Walters, May 19 2025
Trademarks
donation money for a good cause
Helping others with an IP hook: Brand Action sponsors on 'making a difference'
Professionals from three organisations reveal what led them to sponsor Brand Action and why doing so can build camaraderie
Rani Mehta, May 18 2025
Patents
AdobeStock_444563933_Editorial_Use_Only.jpg
This week on MIP: 10x Genomics and NanoString settle | UPC sides with Amgen
The results of a UK government consultation on the exhaustion of IP rights and an annual review published by the EPO’s Boards of Appeal were also among the top talking points this week
Sukanya Sarkar, May 16 2025
Gift this article